<doc>
  <docmeta id="113hr5214ih">
    <bill congress="113" type="hr" number="5214" version="ih"/>
    <revision size="4425" annotations="0" status="complete" id="7" commit-time="2014-08-06T22:30:37Z" committer="mbohmer" doc="113hr5214ih/7.xml">
      <description>Edited via AKN</description>
    </revision>
  </docmeta>
  <bill bill-stage="Introduced-in-House" bill-type="olc" dms-id="H9A3651C72C1142D38F1DB5FEA0F484BC" public-private="public">
	<metadata>
<dublinCore>
<dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">113 HR 5214 IH: To require the Secretary of Health and Human Services to provide for recommendations for the development and use of clinical data registries for the improvement of patient care.</dc:title>
<dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">U.S. House of Representatives</dc:publisher>
<dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2014-07-28</dc:date>
<dc:format xmlns:dc="http://purl.org/dc/elements/1.1/">text/xml</dc:format>
<dc:language xmlns:dc="http://purl.org/dc/elements/1.1/">EN</dc:language>
<dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/">Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
		<distribution-code display="yes">I</distribution-code>
		<congress>113th CONGRESS</congress>
		<session>2d Session</session>
		<legis-num>H. R. 5214</legis-num>
		<current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber>
		<action>
			<action-date date="20140728">July 28, 2014</action-date>
			<action-desc>
        <sponsor name-id="O000168">Mr. Olson</sponsor> introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name>
      </action-desc>
		</action>
		<legis-type>A BILL</legis-type>
		<official-title>To require the Secretary of Health and Human Services to provide for recommendations for the
			 development and use of clinical data registries for the improvement of
			 patient care.</official-title>
	</form>
	<legis-body id="HD461B1619F50477C808E494EDCBE3793" style="OLC">
		<section id="H3CF28158081E43E7B6B93377BC1614CC" section-type="section-one">
      <enum>1.</enum>
      <header>Recommendations for development and use of clinical data registries</header>
			<subsection id="HCEF32D4112494A48989985BF7F8A30DE">
        <enum>(a)</enum>
        <header>In general</header>
        <text display-inline="yes-display-inline">Not later than one year after the date of the enactment of this Act, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary of Health and
			 Human Services</cato:entity-ref> shall make recommendations for the development and use,
			 when appropriate, of clinical data registries that are integrated with
			 clinical practice guidelines and best practices or standards of care,
			 including registries designed to minimize duplication and burden on those
			 operating or reporting to such registries, for the improvement of patient
			 care. The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall make such recommendations available to the
			 public by posting them on a public Website of the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Department of Health and
			 Human Services</cato:entity-ref>.</text>
			</subsection>
      <subsection id="H7F9666F2A5374A0F97329D72DB860F9A">
        <enum>(b)</enum>
        <header>Specific recommendations</header>
        <text>Such recommendations, with respect to such registries, shall include the following:</text>
				<paragraph id="HBC3E523B19F74A4F8D81FADFBBF838CE">
          <enum>(1)</enum>
          <text>Recommendations for a set of standards that, if adopted by such registries, would allow for the
			 bidirectional, interoperable exchange of information between the
			 electronic health records of the reporting clinicians and such registries.</text>
				</paragraph>
        <paragraph id="H5AC70073A01948418712BBB729BCCB42">
          <enum>(2)</enum>
          <text>Recommendations on how clinical registries, including outcomes-based registries, may be developed
			 and then used to evaluate various care models and methods, including
			 improved clinical care coordination, and the impact of such models and
			 methods on the management of diseases as measured by appropriate care
			 parameters based on clinical practice guidelines and best practices (such
			 as A1C, blood pressure, and cholesterol levels in the case of diabetes).</text>
				</paragraph>
        <paragraph id="H0A2500BC40C444CFAD0E36F1AE3CF90D">
          <enum>(3)</enum>
          <text>Recommendations on how such registries should be structured to facilitate the recording and
			 reporting of post-market data for the purposes of monitoring safety and
			 efficacy of <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7524" entity-type="federal-body">FDA</cato:entity-ref>-approved devices and drugs, reporting relevant clinical
			 data to satisfy attestation requirements for coverage of prescribed
			 devices and drugs, and better defining appropriate clinical use in support
			 of evidence development for the Medicare program (such as improving
			 patient access to safe and effective glucose monitoring systems and future
			 glucose monitoring technologies).</text>
				</paragraph>
        <paragraph id="HA726974D06244660AC04AE8190564268">
          <enum>(4)</enum>
          <text>Recommendations on how data from such registries may be used to inform physicians and other health
			 care professionals regarding clinical practices for the prevention of
			 diseases (such as diabetes and the precursor conditions of diabetes) and
			 appropriate methods for the dissemination of clinical practice support
			 tools and other educational resources that may be derived from registry
			 data.</text>
				</paragraph>
        <paragraph id="HF898FA38658D48BEBCC00E55EA870281">
          <enum>(5)</enum>
          <text>Recommendations for how registries can be used to promote preventive health benefits such as
			 screenings and the Medicare annual wellness visits that may reduce the
			 risk of chronic diseases (such as obesity, osteoporosis, cardiovascular
			 disease, cancer, diabetes and their complications).</text>
				</paragraph>
      </subsection>
      <subsection id="HA128856789C94B21A9979DE822AF5C19">
        <enum>(c)</enum>
        <header>Consultation with clinical experts</header>
        <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall consult with national medical specialty societies and with manufacturers of
			 drugs and medical devices in the development of such recommendations as
			 they relate to the diseases that they (or their manufactured drugs or
			 devices) manage and treat (such as with endocrinologists with respect to
			 recommendations relating to diabetes and pre-diabetes conditions).</text>
			</subsection>
    </section>
  </legis-body>
</bill>
</doc>